IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 511-519

  Keane, Michael P ^a   Gomperts, Brigitte N ^a   Weigt, Samuel ^a   Xue, Ying Ying ^a   Burdick, Marie D ^d   Nakamura, Hiromi ^a   Zisman, David A ^a   Ardehali, Abbas ^a   Saggar, Rajan ^a   Lynch III, Joseph P ^a   Hogaboam, Cory ^b   Kunkel, Steven L ^b   Lukacs, Nicholas W ^b   Ross, David J ^a   Grusby, Michael J ^c   Strieter, Robert M ^d   Belperio, John A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CYCLOSPORIN; CYCLOSPORIN A; INTERLEUKIN 13; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG FIBROSIS; LUNG GRAFT REJECTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33845922119     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.511     Document Type: Article

References (39)

1. Arcasoy, S. M., and R. M. Kotloff. 1999. Lung transplantation. N. Engl. J. Med. 340: 1081-1091.
2. Gorczynski, R. M., and D. Wojcik. 1994. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J. Immunol. 152: 2011-2019.
3. VanBuskirk, A. M., M. E. Wakely, and C. G. Orosz. 1996. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 62: 229-238.
4. Piccotti, J. R., K. Li, S. Y. Chan, E. J. Eichwald, and D. K. Bishop. 1999. Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process. Transplantation 67: 1548-1555.
5. Beauregard, C., C. Stevens, E. Mayhew, and J. Y. Niederkom. 2005. Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J. Immunol. 174: 6577-6581.
6. Grunstein, M. M., H. Hakonarson, I. Leiter, M. Chen, R. Whelan, J. S. Grunstein, and S. Chuang. 2002. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am. J. Physiol. 282: L520-L528.
7. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
8. Zurawski, S. M., P. Chomarat, O. Djossou, C. Bidaud, A. N. McKenzie, P. Miossec, I. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270: 13869-13878.
9. Wynn, T. A., M. Hesse, N. G. Sandler, M. Kaviratne, K. F. Hoffmann, M. G. Chiaramonte, R. Reiman, A. W. Cheever, J. P. Sypek, and M. M. Mentink-Kane. 2004. P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon γ and the IL-13 decoy receptor. Hepatology 39: 676-687.
10. Feng, N., S. M. Lugli, B. Schnyder, J. F. Gauchat, P. Graber, E. Schlagenhauf, B. Schnarr, M. Wiederkehr-Adam, A. Duschl, M. H. Heim, et al. 1998. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor α2. Lab. Invest. 78: 591-602.
11. Wood, N., M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, et al. 2003. Enhanced interleukin (1L)-13 responses in mice lacking IL-13 receptor α2. J. Exp. Med. 197: 703-709.
12. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, and T. A. Wynn. 2003. Regulation and function of the interleukin 13 receptor α2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197: 687-701.
13. Bernard, J., D. Treton, C. Vermot-Desroches, C. Boden, P. Horellou, E. Angevin, P. Galanaud, J. Wijdenes, and Y. Richard. 2001. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13. Lab. Invest. 81: 1223-1231.
14. Belperio, J. A., M. D. Burdick, M. P. Keane, Y. Y. Xue, J. P. Lynch III, B. L. Daugherty, S. L. Kunkel, and R. M. Stricter. 2000. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J. Immunol. 165: 461-472.
15. Belperio, I. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, A. Berlin, D. J. Ross, S. L. Kunkel, I. F. Charo, and R. M. Stricter. 2001. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest. 108: 547-556.
16. Belperio, J. A., B. DiGiovine, M. P. Keane, M. D. Burdick, Y. Ying Xue, D. J. Ross, J. P. Lynch III, S. L. Kunkel, and R. M. Stricter. 2002. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Transplantation 73: 591-599.
17. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Stricter. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 169: 1037-1049.
18. Yousem, S. A., G. J. Berry, P. T. Cagle, D. Chamberlain, A. N. Husain, R. H. Hruban, A. Marchevsky, N. P. Ohori, J. Ritter, S. Stewart, and H. D. Tazelaar. 1996. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J. Heart Lung Transplant. 15: 1-15.
19. Belperio, J. A., M. P. Keane, M. D. Burdick, V. Londhe, Y. Y. Xue, K. Li, R. J. Phillips, and R. M. Stricter. 2002. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110: 1703-1716.
20. Ruth, J. H., K. S. Warmington, X. Shang, P. Lincoln, H. Evanoff, S. L. Kunkel, and S. W. Chensue. 2000. Interleukin 4 and 13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks. Cytokine 12: 432-444.
21. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, R. M. Strieter, and S. L. Kunkel. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164: 2738-2744.
22. Tekkanat, K. K., H. F. Maassab, D. S. Cho, J. J. Lai, A. John, A. Berlin, M. H. Kaplan, and N. W. Lukacs. 2001. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J. Immunol. 166: 3542-3548.
23. Blease, K., C. Jakubzick, J. Westwick, N. Lukacs, S. L. Kunkel, and C. M. Hogaboam. 2001. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J. Immunol. 166: 5219-5224.
24. Belperio, J. A., M. Dy, M. D. Burdick, Y. Y. Xue, K. Li, J. A. Elias, and M. P. Keane. 2002. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 27: 419-427.
25. Lukacs, N. W., K. K. Tekkanat, A. Berlin, C. M. Hogaboam, A. Miller, H. Evanoff, P. Lincoln, and H. Maassab. 2001. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 167: 1060-1065.
26. Dik, W. A., L. J. Zimmermann, B. A. Naber, D. J. Janssen, A. H. van Kaam, and M. A. Versnel. 2003. Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr. Pulmonol. 35: 34-41.
27. Rolfe, M. W., S. L. Kunkel, T. J. Standiford, M. B. Orringer, S. H. Phan, H. L. Evanoff, M. D. Burdick, and R. M. Stricter. 1992. Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am. J. Physiol. 263: L536-L545.
28. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Stricter. 2003. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J. Immunol. 171: 4844-4852.
29. Zheng, L., C. Ward, G. I. Snell, B. E. Orsida, X. Li, J. W. Wilson, T. J. Williams, and E. H. Walters. 1997. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am. J. Respir. Crit. Care Med. 155: 2072-2077.
30. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167: 4668-4675.
31. Powell, T. J., Jr., and J. W. Streilein. 1990. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J. Immunol. 144: 854-859.
32. Donckier, V., M. Wissing, C. Bruyns, D. Abramowicz, M. Lybin, M. L. Vanderhaeghen, and M. Goldman. 1995. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 59: 1571-1576.
33. Jakubzick, C., S. L. Kunkel, R. K. Puri, and C. M. Hogaboam. 2004. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol. Res. 30: 339-349.
34. Hancock, A., L. Armstrong, R. Gama, and A. Millar. 1998. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell Mol. Biol. 18: 60-65.
35. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
36. Rankin, J. A., D. E. Picarella, G. P. Geba, U. A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93: 7821-7825.
37. Fichtner-Feigl, S., W. Strober, K. Kawakami, R. K. Puri, and A. Kitani. 2006. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat. Med. 12: 99-106.
38. Lossos, I. S., R. Or, V. Ginzburg, T. G. Christensen, Y. Mashriki, and R. Breuer. 2002. Cyclosporin A up-modulates bleomycin-induced pulmonary fibrosis in BALB/c mice. Respiration 69: 344-349.
39. Hussain, I., M. S. Piepenbrink, K. J. Fitch, J. A. Marsh, and R. R. Dietert. 2005. Developmental immunotoxicity of cyclosporin-A in rats: age-associated differential effects. Toxicology 206: 273-284.